PharmiWeb.com - Global Pharma News & Resources
17-Dec-2018

East River BioSolutions Announces Rebrand to Xylyx Bio

BROOKLYN, N.Y., Dec. 17, 2018 /PRNewswire/ -- East River BioSolutions, a biotech company specializing in cell-specific extracellular matrix biomaterials, today announced its rebrand to Xylyx Bio. The Company's proprietary platform enables scientific discovery and tissue regeneration in several multibillion-dollar markets, including cell culture and therapeutics. The comprehensive new branding underscores the Company's focus on accelerating science for improved human health and includes a new logo and website.

The name Xylyx is derived from 'xylo-,' the Greek root for 'wood,' thus encompassing the central importance of the natural environment. The dual x's echo the sound of 'extracellular matrix,' the technical name for the natural cell environment, while the lines of the x's and y's create a visual network that reflects the intersecting fibers of the extracellular matrix.

The Xylyx logo brings a sharp visual identity that is bold and scientific. The encircling lines are comprised of multiple intersecting elements, representing the Company's expertise in different markets. The Company's focus on providing the full suite of components in the extracellular microenvironment is reflected in its tagline, "The Cell Environment Company."

"Xylyx Bio continues to offer bio-inspired products that enable the most accurate and physiologically relevant results for scientists working in cell culture, supporting cell models that are more predictive of human physiology and thus facilitating acceleration of pharmaceutical drug discovery and development," explained Andrea Nye, Xylyx Bio President and CEO. "In addition, with deep scientific expertise in biomaterials and tissue regeneration, we are addressing multiple pressing unmet clinical needs. Our new brand better establishes the Company and its strength in the marketplace and biotech ecosystem overall."

Dr. John O'Neill, Xylyx Bio Co-Founder and Chief Scientific Officer, continued, "As we champion the paradigm shift toward more biologically relevant platforms for cells studied outside the body and regeneration within the body, we sought a name and brand that conveys our focus on extracellular matrix as well as our mission to create and deliver effective science-based solutions for the benefit of human life and health."

About Xylyx Bio

Xylyx Bio empowers the most actionable scientific discoveries and effective tissue regeneration through the development of cell-specific biomaterials, providing native physiological microenvironments to support cell health both inside and outside the body.  

Contact
Xylyx Bio, Inc.
Andrea Nye, CEO
andrea@xylyxbio.com

Editor Details

Related Links

Last Updated: 17-Dec-2018